retatrutide peptide reviews vs Tirzepatide (2026): Differences in Weight Loss, Metabol – Revolution Health & Wellness Retatrutide Significantly Reduces Visceral Fat

Led by the results of cotadutide, GLP-1/glucagon co-agonists have been shown to have promising weight loss and glycaemic effects in these early phase clinical results however data from later phase clinical trials are expected later this year/early next year

Exenatide ER (Bydureon) A long-acting GLP-1 receptor agonist that supports glycaemic control and weight management through delayed gastric emptying and increased satiety

Support Healthy Blood Sugar Levels*

Semaglutide is a glucagon-like peptide-1 (GLP-1) receptor agonist used for type 2 diabetes and weight management, and exposure to elevated temperatures during shipping may compromise its therapeutic properties

Companies are buying rather than building, says Johnson, as they weigh certainty against getting a foothold in the market

Introduction:In the dynamic landscape of medical weight loss, GLP-1 medications have become a beacon of hope